The Hidden Threat in Psoriasis Care

Cardiovascular disease (CVD) stands as the primary cause of mortality for individuals living with psoriasis. Despite this well-established link, structured psoriasis cardiovascular risk prevention is frequently absent from standard dermatological workflows. Chronic systemic inflammation in psoriasis accelerates atherosclerosis, making early intervention critical. A recent randomized clinical trial, the TEXTME PSO study, explored whether a mobile health (mHealth) intervention could effectively engage patients in managing these systemic risks.

The TEXTME PSO Trial Design

This single-center study, conducted in Australia, randomized 111 adults with dermatologist-confirmed psoriasis. The intervention group participated in the TEXTME PSO program, which delivered four automated text messages per week for six months. These messages focused on healthy lifestyle choices, including diet, exercise, and smoking cessation. Meanwhile, the control group received standard care. Researchers primarily measured changes in the 13-item Patient Activation Measure (PAM), which gauges a patient’s confidence and knowledge in managing their health.

Strengthening Psoriasis Cardiovascular Risk Prevention

The results were compelling. Participants receiving the text messages showed a statistically significant improvement in patient activation scores compared to the usual care group. Furthermore, the intervention group demonstrated better adherence to the Mediterranean diet and increased levels of physical activity. Additionally, patients exhibited a deeper understanding of the link between their skin condition and heart health. These findings suggest that simple, low-cost digital tools can effectively bridge the gap in preventive care.

For clinicians in India, where psoriasis prevalence is significant and CVD burden is high, these insights are particularly valuable. Utilizing mHealth strategies allows for continuous patient support outside the clinic. Consequently, healthcare providers can empower patients to adopt heart-healthy habits, addressing the systemic nature of psoriatic disease beyond just skin lesions.

Frequently Asked Questions

What is the Patient Activation Measure (PAM)?

PAM is a validated 13-item scale that assesses an individual\'s knowledge, skill, and confidence for self-management of their health. Higher scores indicate more empowered and proactive patients.

How often were text messages sent in the TEXTME PSO study?

Participants in the intervention group received four text messages every week. These messages covered various topics, including tobacco cessation, exercise, and dietary improvements.

Why is cardiovascular screening important for psoriasis patients?

Psoriasis is an independent risk factor for myocardial infarction and stroke due to shared inflammatory pathways. Proactive screening ensures that modifiable risk factors like hypertension and obesity are managed early.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Smith A et al. Text Messaging for Cardiovascular Risk Prevention in Psoriasis: A Randomized Clinical Trial. JAMA Dermatol. 2026 May 13. doi: 10.1001/jamadermatol.2026.1070. PMID: 42126867.

Bansal M et al. The Use of Screening Tools for Cardiovascular Risk Assessment in Psoriasis – A Case-Control Study. Indian J Dermatol. 2022;67(1):96. doi: 10.4103/ijd.ijd_560_21.

Gelfand JM et al. The Risk of Cardiovascular Disease in Patients with Psoriasis. JAMA. 2006;296(14):1735-1741. doi: 10.1001/jama.296.14.1735.